| Dr Robin L Leight, MD | |
|
147 Allen Street, Rutland, VT 05701-4570 | |
| (802) 775-1901 | |
| (802) 773-2867 |
| Full Name | Dr Robin L Leight |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 147 Allen Street, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235136896 | NPI | - | NPPES |
| 15168 | Other | VT | MVP PROVIDER ID NUMBER |
| 216-18523 | Other | VT | VT BC/BS PROVIDER NUMBER |
| 216-5217 | Other | VT | VT BC/BS GROUP ID NUMBER |
| OVN0354 | Medicaid | VT | |
| 10002699 | Other | VT | CDPHP PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 42-0008483 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Copley Hospital | Morrisville, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Copley Hospital Inc | 9234125766 | 49 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.
Kaiser Health News: Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country"
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
› Verified 1 days ago
| Entity Name | Copley Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922029784 PECOS PAC ID: 9234125766 Enrollment ID: O20040811001413 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.
Kaiser Health News: Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country"
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
› Verified 1 days ago
| Entity Name | Rutland Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083678833 PECOS PAC ID: 7214846377 Enrollment ID: O20040913000323 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.
Kaiser Health News: Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country"
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robin L Leight, MD 147 Allen St, Rutland, VT 05701-4555 Ph: (802) 775-1901 | Dr Robin L Leight, MD 147 Allen Street, Rutland, VT 05701-4570 Ph: (802) 775-1901 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.
Kaiser Health News: Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country"
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.
Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.
ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.
› Verified 1 days ago
Dr. Mary M Beerworth, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 147 Allen Street, Rutland, VT 05701 Phone: 802-775-1901 Fax: 802-773-2867 | |
Dr. Kira L Balkcom, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 147 Allen St, Rutland, VT 05701 Phone: 802-775-1901 Fax: 802-775-1974 | |
Thusitha Cotter, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 147 Allen St, Rutland, VT 05701 Phone: 802-775-1901 Fax: 802-775-1974 | |
Dr. Patrick Keenan, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 147 Allen St, Rutland, VT 05701 Phone: 802-775-1901 Fax: 802-775-1974 | |
Sarah Decker, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 | |
Dr. Ananda Boyer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 147 Allen St, Rutland, VT 05701 Phone: 802-775-1901 Fax: 802-775-1974 |